Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.54 |
| ▸ | TSHR | P16473 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL484003 | 0.85 | CYP3A4 (0.54) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL2888228 | 0.85 | CYP3A4 (0.45) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL15430 | 0.84 | CYP3A4 (0.70) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL28944560 | 0.82 | MIF (0.42) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL29218994 | 0.81 | CYP3A4 (0.50) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL27702459 | 0.81 | CYP3A4 (0.50) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL546217 | 0.81 | CYP3A4 (0.50) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL11856992 | 0.81 | CYP3A4 (0.50) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| Water SCHEMBL28889229 | 0.81 | CYP3A4 (0.67) | CYP3A4TSHRMAPK1TDP1TRPA1 | |
| SCHEMBL27741428 | 0.81 | CYP3A4 (0.67) | CYP3A4TSHRMAPK1TDP1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 571 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4849262-A | Pigment printing pastes and dyeing liquors containing stable dispersions of finely divided solid polyisocyanates | BASF AKTIENGESELLSCHAFT (DE) | 1989-07-18 | — | — | US | claimed |
| US-12606692-B2 | Spectacle lens | HOYA LENS THAILAND LTD. (TH) | 2026-04-21 | — | — | US | disclosed |
| EP-3983466-B1 | AQUEOUS POLYURETHANE DISPERSION | COVESTRO DEUTSCHLAND AG (DE) | 2026-02-18 | — | — | EP | disclosed |
| EP-3778170-B1 | METHOD FOR MANUFACTURING OPTICAL MEMBER | HOYA LENS THAILAND LTD (TH) | 2026-01-28 | — | — | EP | disclosed |
| US-12384124-B2 | Method for producing polarizing lens, polarizing film and polarizing lens | HOYA LENS THAILAND LTD. (TH) | 2025-08-12 | — | — | US | disclosed |
| EP-4396248-B1 | AQUEOUS POLYURETHANE-UREA DISPERSION | COVESTRO DEUTSCHLAND AG (DE) | 2025-08-06 | — | — | EP | disclosed |
| EP-3689932-B1 | METHOD FOR MANUFACTURING OPTICAL MEMBER RESIN, OPTICAL MEMBER RESIN, SPECTACLE LENS, AND SPECTACLES | HOYA LENS THAILAND LTD (TH) | 2025-07-30 | — | — | EP | disclosed |
| US-12359016-B2 | Method of preparing low haze polymer compositions for use in high refractive index optical materials | PPG INDUSTRIES OHIO, INC. (US) | 2025-07-15 | — | — | US | disclosed |
| US-20250188215-A1 | AQUEOUS POLYURETHANE DISPERSION | COVESTRO DEUTSCHLAND AG (DE) | 2025-06-12 | — | — | US | disclosed |
| US-20250188024-A1 | METHOD OF PRODUCING PENTAERYTHRITOL MERCAPTOCARBOXYLATE, POLYMERIZABLE COMPOSITION, RESIN, OPTICAL MATERIAL, AND SPECTACLE LENS | HOYA LENS THAILAND LTD. (TH) | 2025-06-12 | — | — | US | disclosed |
| US-4946923-A | S-alkyl thiocarbamate base resin, plastic lens comprising the resin, and process for making the lens | MITSUI TOATSU CHEMICALS, INC. (JP) | 1990-08-07 | — | — | US | disclosed |
| US-4929707-A | Polyurethane base lens resin, plastic lens comprising the resin and preparation method of the lens | MITSUI TOATSU CHEMICALS, INC. (JP) | 1990-05-29 | — | — | US | disclosed |
| EP-0330363-A2 | Highly-refractive plastic lens and process for making the lens | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-08-30 | — | — | EP | disclosed |
| EP-0329386-A2 | S-alkyl thiocarbamate base resin, plastic lens comprising the resin, and process for making the lens | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-08-23 | — | — | EP | disclosed |
| EP-0130462-A2 | Printed circuits | AMOCO CORPORATION (US) | 1985-01-09 | — | — | EP | disclosed |
| EP-0070324-A1 | Apparatus for producing a curable polyurethane froth | UNION CARBIDE CORPORATION (US) | 1983-01-26 | — | — | EP | disclosed |
| EP-0069163-A1 | A frothable polyurethane composition and a cellular foam produced therefrom | UNION CARBIDE CORPORATION (US) | 1983-01-12 | — | — | EP | disclosed |
| US-4316875-A | Apparatus for producing a curable polyurethane froth | UNION CARBIDE CORPORATION (US) | 1982-02-23 | — | — | US | disclosed |
| US-4275172-A | Frothable polyurethane composition and a cellular foam produced therefrom suitable for use in joints between wallboards | UNION CARBIDE CORPORATION (US) | 1981-06-23 | — | — | US | disclosed |
| US-3994742-A | SULFUR COMPOUNDS CONTAINING AT LEAST TWO AMINO OR IMINO GROUPS | PPG INDUSTRIES, INC. (US) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606692-B2 | Spectacle lens | POT1, TCOF1, CRY1 | CYP3A4 4631/4885TSHR 329/4885MAPK1 1827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.